From Organic Consumers Association:
Dupont Dame Follows Monsanto Men Into Obama Administration
Starting with his choice for USDA Secretary, the pro-biotech former governor of Iowa, Tom Vilsack, President Obama has let Monsanto, Dupont and the other pesticide and genetic engineering companies know they’ll have plenty of friends and supporters within his administration.
President Obama has taken his team of food and farming leaders directly from the biotech companies and their lobbying, research, and philanthropic arms.
Michael Taylor, former Monsanto Vice President, is now the FDA Deputy Commissioner for Foods.
Roger Beachy, former director of the Monsanto-funded Danforth Plant Science Center, is now the director of the USDA National Institute of Food and Agriculture.
Islam Siddiqui, Vice President of the Monsanto and Dupont-funded pesticide-promoting lobbying group, CropLife, is now the Agriculture Negotiator for the US Trade Representative.
Rajiv Shah, former Gates Foundation agricultural-development director served as Obama’s USDA Under Secretary for Research Education and Economics and Chief Scientist and is now head of USAID.
Now, Ramona Romero, corporate counsel to Dupont, has been nominated by President Obama to serve as General Counsel for the U.S. Department of Agriculture.
Tell Your Senators to Reject Ramona Romero and President Obama to Get Monsanto and Dupont Out of His Administration!
Monsanto employees and government regulatory agencies
employees are the same people!
Date: Tue, 07 Dec 1999 10:43:59 -0600
From: Peter Khaled <[email protected]>
Subject: Revolving Door - Updated list - FYI
David W. Beier . . .former head of Government Affairs for
Genentech, Inc., . . .now chief domestic policy advisor to Al
Gore, Vice President of the United States.
Linda J. Fisher . . .former Assistant Administrator of the
United States Environmental Protection Agency's Office of
Pollution Prevention, Pesticides, and Toxic Substances, . . .now
Vice President of Government and Public Affairs for Monsanto
Michael A. Friedman, M.D. . . former acting commissioner of
the United States Food and Drug Administration (FDA)
Department of Health and Human Services . . .now senior
vice-president for clinical affairs at G. D. Searle & Co., a
pharmaceutical division of Monsanto Corporation.
L. Val Giddings . . . former biotechnology regulator and
(biosafety) negotiator at the United States Department of
Agriculture (USDA/APHIS), . . .now Vice President for Food &
Agriculture of the Biotechnology Industry Organization (BIO).
Marcia Hale . . . former assistant to the President of the
United States and director for intergovernmental affairs, . .
.now Director of International Government Affairs for Monsanto
Michael (Mickey) Kantor. . . former Secretary of the United
States Department of Commerce and former Trade
Representative of the United States, . . .now member of the
board of directors of Monsanto Corporation.
Josh King . . . former director of production for White House
events, . . . now director of global communication in the
Washington, D.C. office of Monsanto Corporation.
Terry Medley . . . former administrator of the Animal and
Plant Health Inspection Service (APHIS) of the United States
Department of Agriculture, former chair and vice-chair of the
United States Department of Agriculture Biotechnology Council,
former member of the U.S. Food and Drug Administration (FDA)
food advisory committee, . . . and now Director of Regulatory
and External Affairs of Dupont Corporation's Agricultural
Margaret Miller . . . former chemical laboratory supervisor for
Monsanto, . . .now Deputy Director of Human Food Safety and
Consultative Services, New Animal Drug Evaluation Office,
Center for Veterinary Medicine in the United States Food and
Drug Administration (FDA).*
Michael Phillips . . . recently with the National Academy of
Science Board on Agriculture . . . now head of regulatory affairs
for the Biotechnology Industry Organization.
William D. Ruckelshaus . . . former chief administrator of the
United States Environmental Protection Agency (USEPA), . .
.now (and for the past 12 years) a member of the board of
directors of Monsanto Corporation.
Michael Taylor . . . former legal advisor to the United States
Food and Drug Administration (FDA)'s Bureau of Medical
Devices and Bureau of Foods, later executive assistant to the
Commissioner of the FDA, . . . still later a partner at the law
firm of King & Spaulding where he supervised a nine-lawyer
group whose clients included Monsanto Agricultural Company, .
. . still later Deputy Commissioner for Policy at the United
States Food and Drug Administration, . . . and later with the
law firm of King & Spaulding. . . . now head of the
Washington, D.C. office of Monsanto Corporation.*
Lidia Watrud . . . former microbial biotechnology researcher at
Monsanto Corporation in St. Louis, Missouri, . . .now with the
United States Environmental Protection Agency Environmental
Effects Laboratory, Western Ecology Division.
Jack Watson. . .former chief of staff to the President of the
United States, Jimmy Carter, . . .now a staff lawyer with
Monsanto Corporation in Washington, D.C.
Clayton K. Yeutter . . . former Secretary of the U.S.
Department of Agriculture, former U.S. Trade Representative
(who led the U.S. team in negotiating the U.S. Canada Free
Trade Agreement and helped launch the Uruguay Round of the
GATT negotiations), now a member of the board of directors of
Mycogen Corporation, whose majority owner is Dow
AgroSciences, a wholly owned subsidiary of The Dow Chemical
Larry Zeph . . . former biologist in the Office of Prevention,
Pesticides, and Toxic Substances, U.S. Environmental
Protection Agency, . . . now Regulatory Science Manager at
Pioneer Hi-Bred International.
*Margaret Miller, Michael Taylor, and Suzanne Sechen (an FDA
"primary reviewer for all rbST and other dairy drug production applications"
) were the subjects of a U.S. General Accounting Office (GAO) investigation in
1994 for their role in the U.S. Food and Drug Administration's approval of
Posilac, Monsanto Corporation's formulation of recombinant bovine growth
hormone (rbST or rBGH). The GAO Office found "no conflicting financial
interests with respect to the drug's approval" and only "one minor deviation from
now superseded FDA regulations". (Quotations are from the 1994 GAO
The Jewish Monsanto Family of Louisiana included Benjamin, Isaac, Manuel, Eleanora, Gracia and Jacob. They made frequent purchases of Blacks including twelve in 1785, thirteen and then thirty-one in 1787, and eighty in 1768.
In 1794, Benjamin sold "Babet," a Black woman, to Franco Cardel. Manuel sold two Blacks from Guinea named "Polidor" and "Lucy" to James Saunders for $850 in silver.
As individuals they were owners of Africans whom they named "Quetelle," "Valentin," "Baptiste," "Prince," "Princess," "Ceasar," "Dolly," "Jen," "Fanchonet," "Rozetta," "Mamy," "Sofia," and many others. Isaac repeatedly mortgaged four of these when in financial trouble.
Benjamin Monsanto of Natchez, Mississippi entered into at least 6 contracts for the sale of his slaves which would take place after his death. Gracia bequeathed nine Africans to her relatives in her 1790 will, and Eleanora also held Blacks as slaves.
Manuel Jacob Monsanto entered into at least 12 contracts for sale of slaves between 1787 and 1789 in Natchez and New Orleans, Louisiana.
"His family consists of himself and seven Negroes."
Later, "Jacob Monsanto, son of Isaac Rodrigues Monsanto, one of the very first known Jews to settle in New Orleans, owner of a several-hundred-acre plantation at Manchac, fell in love with his slave, Mamy or Maimi William. Their daughter Sophia, grew up to be a lovely quadroon."
Monsanto was founded in St. Louis, Missouri, in 1901, by John Francis Queeny, a 30-year veteran of the pharmaceutical industry. He funded the start-up with his own money and capital from a soft drink distributor, and gave the company his wife's maiden name. His father in law was Emmanuel Mendes de Monsanto, wealthy financier of a sugar company active in Vieques, Puerto Rico and based in St. Thomas in the Danish West Indies. The company's first product was the artificial sweetener saccharin, which it sold to the Coca-Cola Company. It also introduced caffeine and vanillin to Coca-Cola, and became one of that company's main suppliers.
In 1919, Monsanto established its presence in Europe by entering into a partnership with Graesser's Chemical Works at Cefn Mawr near Ruabon, Wales to produce vanillin, salicylic acid, aspirin and later rubber.
In its third decade, the 1920s, Monsanto expanded into basic industrial chemicals like sulfuric acid, and the decade ended with Queeny's son Edgar Monsanto Queeny taking over the company in 1928.
The 1940s saw Monsanto become a leading manufacturer of plastics, including polystyrene, and synthetic fibers. Since then, it has remained one of the top 10 US chemical companies. Other major products have included the herbicides 2,4,5-T, DDT, and Agent Orange used primarily during the Vietnam War as a defoliant agent (later proven to be highly carcinogenic to any who come into contact with the solution), the artificial sweetener aspartame (NutraSweet), bovine somatotropin (bovine growth hormone (BST)), and PCBs. Also in this decade, Monsanto operated the Dayton Project, and later Mound Laboratories in Miamisburg, Ohio, for the Manhattan Project, the development of the first nuclear weapons and, after 1947, the Atomic Energy Commission.
Monsanto began manufacturing DDT in 1944, along with some 15 other companies. The use of DDT in the U.S. was banned by Congress in 1972, due in large part to efforts by environmentalists, who persisted in the challenge put forth by Rachel Carson and her book Silent Spring in 1962, which sought to inform the public of the side effects associated with the insecticide, which had been much-welcomed in the fight against malaria-transmitting mosquitoes. As the decade ended, Monsanto acquired American Viscose from England's Courtauld family in 1949.
In 1954, Monsanto partnered with German chemical giant Bayer to form Mobay and market polyurethanes in the US.
In 1968, Monsanto became the first organization to mass-produce visible LEDs, using gallium arsenide phosphide to produce red LEDs suitable for indicators.
Monsanto was a pioneer of optoelectronics in the 1970s. In 1968 they became the first company to start mass production of Light Emitting Diodes (LEDs). This ushered in the era of solid-state lights. From 1968 to 1970 sales doubled every few months. Their products (discrete LEDs and seven-segment numeric displays) became the standards of industry. The primary markets then were electronic calculators, digital watches, and digital clocks.
In the 1960s and 1970s, Monsanto became one of 10-36 producers of Agent Orange for US Military operations in Vietnam.
In 1980, Monsanto established the Edgar Monsanto Queeny safety award in honor of its former CEO (1928–1960), to encourage accident prevention.
Monsanto scientists became the first to genetically modify a plant cell in 1982. Five years later, Monsanto conducted the first field tests of genetically engineered crops.
Through a process of mergers and spin-offs between 1997 and 2002, Monsanto made a transition from chemical giant to biotech giant. Part of this process involved the 1999 sale by Monsanto of their phenylalanine facilities to Great Lakes Chemical Corporation (GLC) for $125 million. In 2000, GLC sued Monsanto because of a $71 million dollar shortfall in expected sales.
In 2001, retired Monsanto chemist William S. Knowles was named a co-winner of the Nobel Prize in Chemistry for his research on catalytic asymmetric hydrogenation, which was carried out at Monsanto beginning in the 1960s until his 1986 retirement.
Throughout 2004 and 2005, Monsanto filed lawsuits against many farmers in Canada and the U.S. on the grounds of patent infringement, specifically the farmers' sale of seed containing Monsanto's patented genes. In some cases, farmers claimed the seed was unknowingly sown by wind carrying the seeds from neighboring crops, a claim rejected in Monsanto Canada Inc. v. Schmeiser. These instances began in the mid to late 1990s, with one of the most significant cases being decided in Monsanto's favor by the Canadian Supreme Court. By a 5-4 vote in late May 2004, that court ruled that "by cultivating a plant containing the patented gene and composed of the patented cells without license, the appellants (canola farmer Percy Schmeiser) deprived the respondents of the full enjoyment of the patent." With this ruling, the Canadian courts followed the U.S. Supreme Court in its decision on patent issues involving plants and genes.
As of February 2005, Monsanto has patent claims on breeding techniques for pigs which would grant them ownership of any pigs born of such techniques and their related herds. Greenpeace claims Monsanto is trying to claim ownership on ordinary breeding techniques. Monsanto claims that the patent is a defensive measure to track animals from its system. They furthermore claim their patented method uses a specialized insemination device that requires less sperm than is typically needed.
In 2006, the Public Patent Foundation filed requests with the United States Patent and Trademark Office to revoke four patents that Monsanto has used in patent lawsuits against farmers. In the first round of reexamination, claims in all four patents were rejected by the Patent Office in four separate rulings dating from February through July 2007. Monsanto has since filed responses in the reexaminations.
In October 2008, the company's Canadian division, Monsanto Canada Inc., was named one of Canada's Top 100 Employers by Mediacorp Canada Inc., and was featured in Maclean's newsmagazine. Later that month, Monsanto Canada Inc. was also named one of Manitoba's Top Employers, which was announced by the Winnipeg Free Press newspaper....
Are you just flaunting that you are an anti-semitic jerk? I find you to be a bit of a naval gazing idiot, but only recently has you bigotry started to rear it's ugly head.